CA Patent

CA2617805A1 — Novel formulations comprising fenofibrate and a statin, and related methods of treatment

Assigned to Transform Pharmaceuticals Inc · Expires 2007-02-15 · 19y expired

What this patent protects

The invention provides novel omega-3 oil formulations comprising fenofibrate and a statin. These formulations are effective in small volumes. Related methods of treatment are also described.

USPTO Abstract

The invention provides novel omega-3 oil formulations comprising fenofibrate and a statin. These formulations are effective in small volumes. Related methods of treatment are also described.

Drugs covered by this patent

Patent Metadata

Patent number
CA2617805A1
Jurisdiction
CA
Classification
—
Expires
2007-02-15
Drug substance claim
No
Drug product claim
No
Assignee
Transform Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.